TADAWUL •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/08/2026 10:44
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTADAWUL
Market Capitalization2,061.5 mln
Float15.09 mln
Earnings Date03/27/2025
EPS
2.98
Solid
P / E
19.58
Moderately valued
Beneish M-Score
-2.06
Caution advised
1-Year Forecast
83.66
Exceptional upside
Relative Strength
65
/ 100
Outperforming
Debt / Equity
0.20
Very low leverage
Business Description
Founded in 1998 and based in Riyadh, Saudi Arabia, Middle East Pharmaceutical Industries Company develops, produces, and sells a wide range of generic medicines and medical preparations both within the Kingdom and in international markets. The company serves public and private healthcare customers as well as export markets, with products covering treatments for the skin, lungs, heart, digestive system, infections, bones, and the nervous system.
